DJ Biogen Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Biogen Inc. $(BIIB)$ slid 1.32% to $219.88 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.73% to 7,722.72 and the Dow Jones Industrial Average rising 0.49% to 51,176.96.
This was the stock's fourth consecutive day of losses.
Biogen Inc. closed 4.60% short of its 52-week high of $230.49, which the company achieved on September 28th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 1.02% to $256.03, Pfizer Inc. $(PFE)$ fell 1.14% to $27.80, and AbbVie Inc. $(ABBV)$ rose 1.11% to $262.82.
Trading volume (774,017) remained 180,740 below its 50-day average volume of 954,757.
Data source: Dow Jones Market Data, FactSet. Data compiled October 2, 2026.